The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References

Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below. 

4 – Taoufiq Harach et al., Scientific Reports 7, 41802, February 2017

Reduction of Abeta Amyloid Pathology in APPPS1 Transgenic Mice in the Absence of Gut Microbiota

5 – Laura Bonfili et al., Scientific Reports 7, 2426, May 2017

Microbiota Modulation Counteracts Alzheimer’s Disease Progression Influencing Neuronal Proteolysis and Gut Hormones Plasma Levels

6 – Laura Bonfili et al., Molecular Neurobiology 55, no. 10, 7987–8000, October 2018

SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Model

7 – Li Wen and Andrew Duffy, Journal of Nutrition 147, no. 7, 1468S–75S, June 2017

Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes

7 – Yasmine Belkaid and Timothy Hand, Cell 157, no. 1, 121–41, March 2014

Role of the Microbiota in Immunity and Inflammation

8 – William R. Wikoff et al., Proceedings of the National Academy of Sciences 106, no. 10, 3698–703, March 2009

Metabolomics Analysis Reveals Large Effects of Gut Microflora on Mammalian Blood Metabolites

9 – Christensen,L., Ascent2health.com, 2017

Are environmental toxins disrupting your gut bacteria?

10 – Francesca Pistollato et al., Nutrition Reviews 74, no. 10, 624–34, October 2016

Role of Gut Microbiota and Nutrients in Amyloid Formation and Pathogenesis of Alzheimer Disease

11 – Yuhai Zhao and Walter J. Lukiw, Frontiers in Neurology 9, 145, March 2018

Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease

12 – O’Sullivan, E. et al., Beneficial Microbes 2: 199-207, 2011

BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels?